Il Yang Pharmaceutical Co Ltd
007570
Company Profile
Business description
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.
Contact
110, hagal-ro, Giheung-gu
Yongin-si
SeoulGyeonggi
KORT: +82 312817851
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
669
Stocks News & Analysis
stocks
Why stocks sometimes fall for no obvious reason
How the private markets impact all equity investors.
stocks
Poor organic growth obscured by acquisition for ASX listed share
Sales dropped by 2% without impact of acquisition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,877.20 | 15.00 | -0.17% |
| CAC 40 | 8,115.75 | 29.75 | 0.37% |
| DAX 40 | 24,888.56 | 281.79 | 1.15% |
| Dow JONES (US) | 50,579.70 | 294.04 | 0.58% |
| FTSE 100 | 10,466.26 | 22.79 | 0.22% |
| HKSE | 25,606.03 | 219.51 | 0.86% |
| NASDAQ | 26,343.97 | 50.87 | 0.19% |
| Nikkei 225 | 63,339.07 | 1,654.93 | 2.68% |
| NZX 50 Index | 12,991.31 | 113.24 | 0.88% |
| S&P 500 | 7,473.47 | 27.75 | 0.37% |
| S&P/ASX 200 | 8,657.00 | 15.10 | -0.17% |
| SSE Composite Index | 4,112.90 | 35.62 | 0.87% |